0
Other Articles |

SULFAPYRIDINE IN TRACHOMA

M. P. Spearman, M.D.; W. E. Vandevere, M.D.
JAMA. 1939;113(20):1807-1808. doi:10.1001/jama.1939.72800450002008a.
Text Size: A A A
Published online

ABSTRACT

To the growing list of diseases in which sulfapyridine may be found of use we should like to add trachoma. In two cases, herewith reported, we have observed astonishing improvement in the chronic form of the disease when treated with sulfapyridine.

REPORT OF CASES 

Case 1.—  F. F., a white youth aged 15, first seen by us March 11, 1939, had been under treatment for trachoma elsewhere for about one year. Examination showed both corneas markedly opaque. There were no clear areas on either cornea. Vision in both eyes was fingers at 1 foot. Pannus was markedly developed on both corneas. The under surfaces of both upper lids were covered with follicles. The Wassermann and Kahn reactions of the blood were negative. The patient was hospitalized and massive doses of sulfanilamide were given. During the period of hospitalization, covering one month, about 1,000 grains (65 Gm.) of sulfanilamide was given.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs